The DOI matches its Crossref record.
The U.K. Prospective Diabetes Study. A review
Abstract
The objective of the U.K. Prospective Diabetes Study (UKPDS), initiated in 1977, was set up to determine whether improved blood glucose control in people with type 2 diabetes will prevent the complications of diabetes. The UKPDS was also designed to determine whether there are differences between conventional policy (diet therapy) and three different regimens of intensive treatment policy, based on sulfonylurea, metformin, or insulin. Interim efficacy analyses revealed that the intensive policies with sulfonylurea, insulin, and metformin were equally effective in reducing fasting plasma glucose concentrations. However, glucose and HbA1c measurements steadily increased with time, reflecting ongoing deterioration of beta-cell function. Cardiovascular disease was the major cause of complications, and the risk factors included raised LDL cholesterol concentrations, low HDL cholesterol concentrations, elevated blood pressure, elevated HbA1c concentrations, and smoking. A final study report was issued in September 1998, when the median duration of therapy was 11 years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The UK prospective diabetes study showed the importance of dyslipidaemia for cardiovascular disease risk in people with T2D.59”
Citations
Cited by
Sorted by citations
Items 201–268 of 268
Glycated hemoglobin, dyslipidemia and risk of atherosclerosis in type 1 diabetic patients
Ahuja, A., Roopakala, M. S., Wilma Delphine Silvia, C. R., et al. (2011) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-010-0007-x · Cited by 3
Looking beyond overnutrition for causes of epidemic metabolic disease
Poretsky, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213503109 · Cited by 3
Anti-Diabetic Effect of Black Ginseng in C57BLKS/J-db/db Mice
Kang, S., & Kim, A. (2011) · The Korean Journal of Food And Nutrition · doi:10.9799/ksfan.2011.24.4.770 · Cited by 3
Effects of Diabetes and Insulin Resistance on Endothelial Functions
He, Z., Naruse, K., & King, G. L. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:025 · Cited by 3
“In the UKPDS (3,12), more intensive glucose control was associated with a 12% reduction in the risk of pooled macrovascular and microvascular events.”
BackgroundPPAR-γ receptor agonists—a review of their role in diabetic management in Trinidad and Tobago
Smith, S. I. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000041861.79585.4b · Cited by 3
Tablas de riesgo para diabéticos: ¿son realmente necesarias?
Mostaza, J. M., & Lahoz, C. H. (2006) · Medicina Clínica · doi:10.1157/13086851 · Cited by 3
Ohta, T., Sasase, T., Miyajima, K., Matsui, K., Matsushita, M., Furukawa, N., & Yonemori, F. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00419.x · Cited by 3
Amador, L. R., Pérez, J. C. O. S., Faxas, E. B., Valdés, F. F., Rojas, S. B., & Mora, I. (2015) · Acta Médica de Cuba · Cited by 2
Insulin-to-carbohydrate ratios
Mongiello, L. L. (2023) · Nursing · doi:10.1097/01.nurse.0000920448.45572.df · Cited by 2
Global Approach to Cardiovascular Risk in Type 2 Diabetic Persons
Hâncu, N., & Cerghizan, A. (2003) · Springer eBooks · doi:10.1007/978-3-642-59352-9_21 · Cited by 2
Protective Effects of Dimedone Pyrone on Podocytes in Rats with Diabetic Nephropathy
Luan, B., & Sun, C. (2015) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v14i9.14 · Cited by 2
Evaluation of the insulin application system Autopen 24®
Larbig, M., Forst, T. M., Forst, S., et al. (2005) · Practical Diabetes · doi:10.1002/pdi.877 · Cited by 2
The role of hormonal treatment in type 2 diabetes mellitus
Imam, S. K. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s49625 · Cited by 2
“7%).(29) However, the cardiovascular safety of sulfonylureas cannot be considered established unless it is evaluated in long-term cardiovascular outcomes trials.”
Shariatzadeh, N., Zahedirad, M., Neyestani, T., Kalayi, A., Khalaji, N., Gharavi, A., & Soleimani, M. (2013) · Iranian Journal of Nutrition Sciences and Food Technology · Cited by 2
Bondarenko, O. O., & Sorochka, M. (2018) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2018.v0.i3.8987 · Cited by 4
Sheehan, P. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-168-8_1 · Cited by 2
Control of postprandial state abnormalities: meeting the challenge of type 2 diabetes?
Puig‐Domingo, M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.30.s2.4.x · Cited by 2
Planas, A., Simó‐Servat, O., Hernández, C., Ortiz-Zúñiga, Á., Marsal, J. R., Herance, J. R., González, I. F., & Simó, R. (2021) · Research Square · doi:10.21203/rs.3.rs-895697/v1 · Cited by 2
Sheehan, P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-075-1_1 · Cited by 2
Relationship Between Glycemic Control and Cardiovascular Outcomes
Chowdhury, S. R., Tanzil, T., Chowdhury, R. H., & Alam, M. M. (2020) · Chattagram Maa-O-Shishu Hospital Medical College Journal · doi:10.3329/cmoshmcj.v19i2.50043 · Cited by 1
Effects of Diabetes and Insulin Resistance on Endothelial Functions
Fu, J., Yu, M. G., Li, Q., Park, K., & King, G. L. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_3 · Cited by 1
The Timeline of the Association Between Diabetes and Cardiovascular Diseases: A Narrative Review
Luca, S. A., Bungau, R. M., Lazăr, S., Herascu, A., Gaiţă, L., Avram, V. F., & Timar, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196877 · Cited by 1
“Despite the obvious benefits in reducing microvascular complications, it failed to demonstrate a significant reduction in CAD or overall CV events during the initial follow-up period [14,40].”
The impact of evidence-based medicine on diabetes therapy
Görden, P., & Musso, C. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0001-8 · Cited by 1
“Although it is clear that the DCCT, which was carried out in type 1 diabetes, was applicable to type 2 diabetes, the completion of the UKPDS (United Kingdom Prospective Diabetes Study) left no doubt on this issue with respect to risk reduction of retinopathy of 21% and nephropathy of 34%, with only an 11% difference o…”
BackgroundYang, C.-C., Lan, T., Tsai, W., et al. (2021) · Healthcare · doi:10.3390/healthcare9111565 · Cited by 1
“Good diabetes control has already been proven efficacious to prevent many acute and chronic diabetic complications [8].”
BackgroundScreening for Chronic Complications in Type 1 Diabetes
Dorsey, R. R. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Adding a DPP-4 inhibitor to metformin therapy may be safer than you think
Aravind, S. R. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.893867 · Cited by 1
Health and Pro-Longevity Interventions
Vaiserman, A. M., & Lushchak, O. V. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-52663-4_27 · Cited by 1
Medical Nutrition Therapy for Glycemic Control
Mongiello, L. L. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2022.05.005 · Cited by 1
Asiq, M., Jagadeesan, G., Raj, F. J., Ruban, S. A., Muniyandi, K., & Thangaraj, P. (2022) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-0716-2683-2_17 · Cited by 1
10.1016/b978-1-4160-2911-3.50032-7
(2000) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50032-7 · Cited by 1
Arterial hypertension in diabetes: etiology and treatment
Flynn, C. A., & Bakris, G. L. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch74 · Cited by 1
Endocrine and Metabolic Agents
Furman, B. L. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse024 · Cited by 1
Sánchez, O., & Ruiz, J. S. (2007) · Revista Clínica Española · doi:10.1157/13108763 · Cited by 1
Relationship between disinhibition and metabolic control in adolescents with type 1 diabetes
Sanchez, L. (2006) · University Libraries (University of Maryland) · Cited by 1
Gikas, A., Sotiropoulos, A., Tsakountakis, N., et al. (2010) · PubMed · Cited by 1
The need for outcome studies in type 2 diabetes
Dormandy, J. (2002) · The British Journal of Diabetes · doi:10.1177/1474651402002001s0801 · Cited by 1
Nuovo, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-49369-5_7 · Cited by 1
Aslan, İ. S., Başpınar, M. M., Ertan, E., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4956540/v1 · Cited by 1
10.1016/b978-1-4160-2911-3.50034-0
(2000) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50034-0 · Cited by 1
PHYTOMEDICINES FOR FATTY LIVER DISEASE AND FUNCTIONAL GASTROINTESTINAL CONDITIONS
Li, G. Q., Kim, M.-S., Jin, F., & Cho, J. (2015) · Wiley eBooks · doi:10.1002/9781119006039.ch17
Raz, I. (2007) · Drugs · doi:10.2165/00003495-200767040-00008
Krentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_2
“Longitudinal studies have demonstrated progressive and variable, but not inevitable, loss of β-cell function in patients with type 2 diabetes [ 76 , 77 ].”
BackgroundSánchez, O., & Ruiz, J. S. (2008) · Medicina Clínica · doi:10.1157/13116324
Fibrates for type 2 diabetes mellitus
Bonates, M. C., Carvalho, A. P., Albergaria, B., & Valente, O. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009559.pub2
Ink, E. Z. F., Aklander, A. N. L. O. O., Ballantyne, J. C., Abdi, S., Acquadro, M. A., Barna, S. A., & Brenner, G. J. (2005)
Jenugu, V. S., Nyathani, H. K., Prashanth, S., et al. (2011) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2010.3.4.13
Kumar, H., & Jinugu, V. S. (2011)
Editorial Adding a DPP-4 inhibitor to metformin therapy may be safer than you think
Aravind, S. R. (2014)
THE EFFECT OF A HIGH INTENSITY INTERVAL TRAINING PROGRAM ON HEALTH-RELATED OUTCOMES IN OLDER ADULTS
Nieuwoudt, S. (2015) · SUNScholar (Stellenbosch University)
Malec, K., Molęda, P., Homa, K., et al. (2007) · Clinical Diabetology
Insulin Resistance Syndrome and Its Vascular Complications
Thethi, T. K., Bratcher, C., Mallik, T., & Fonseca, V. A. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-26
Short-term aerobic exercise training in type 2 diabetes
Kearney, M. L. (2015) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/50150
Krentz, A. J., & Sinclair, A. J. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch21
Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
Flock, G. B. (2012) · TSpace (University of Toronto)
Metabolic Syndrome – Modern overview of the Problem
Bondarenko, O. O., & Sorochka, M. (2016) · Experimental and Clinical Physiology and Biochemistry · doi:10.25040/ecpb2016.02.045
Produits de glycation avancée et système vasculaire
Wautier, J., & Wautier, M.-P. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70155-3
Malec, K., Molęda, P., Homa, K., et al. (2007) · Via Medica Journals
Gallagher, A. M., Gydesen, H., Jensen, T. J., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-66177/v1
Aiello, L. M., & Cavallerano, J. D. (2004) · doi:10.1002/0470862092.d0909
Arterial Hypertension in Diabetes: Etiology and Treatment
Bakris, G. L., Tarif, N., & Black, H. R. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1006
Burant, C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59651-3_15
Fibrates for type 2 diabetes mellitus
Bonates, M. C., Carvalho, A. P., Albergaria, B., & Valente, O. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009559
Prabhakar, A., Jonathan, G., Woodall, A. K., & Kaye, A. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50141-3_24
Highlights of the Autumn 2002 meeting of the Association of British Clinical Diabetologists
(2003) · Practical Diabetes · doi:10.1002/pdi.448
Paiva, T. A., Sousa, G. A., Gurjão, T. A., de Medeiros, A. C., da Silva, L. E. B., Sousa, F. D. A. R. D. M., Mascarenhas, N. M. H., Maracajá, P. B., Pereira, E. M., de Medeiros, G. R., et al. (2023) · Revista Coopex · doi:10.61223/coopex.v14i5.499
Chen, Y., Wei, X., Lin, T., Lei, Z., Li, J., Kuang, H., xu, X., & Liang, T. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109915 · Cited by 1
Mapping research trends in shared decision-making for type 2 diabetes mellitus: a bibliometric study
Castillo, C. M. S., García-Mera, C., Hernández-Leal, M. J., & Manterola, C. (2026) · Frontiers in Health Services · doi:10.3389/frhs.2026.1799382
“Bridging analysis showsthat Charles (1997) (25), Barry (2012) (26), Elwyn (2012) (27), and Turner (1998) (28) have the highest betweenness.”
Metadata
- Authors
- Turner, R. C.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Turner, Robert C
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1998-12-01
- Volume
- 21
- Issue
- Supplement_3
- Pages
- C35-C38
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2067958701
- Cited by
- 267
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 8 · 2017: 5 · 2016: 10 · 2015: 12 · 2014: 11 · 2013: 5 · 2012: 11
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- UK Prospective Diabetes Study, type 2 diabetes, tight glycemic control, glycemic control, sulfonylureas, metformin, insulin therapy, beta-cell function, cardiovascular complications, cardiovascular risk factors, LDL cholesterol, HDL cholesterol, blood pressure, smoking, HbA1c, dietary therapy
- MeSH terms
- Insulin Secretion, Adult, Aged, Blood Glucose, Demography, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diet, Diabetic, Follow-Up Studies, United Kingdom, Humans, Hypertension, Hypoglycemic Agents, Insulin, Islets of Langerhans, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
